EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Pharmacologic Inhibition of Transient Receptor Potential Ion Channel Ankyrin 1 Counteracts 2-Chlorobenzalmalononitrile Tear Gas Agent–Induced Cutaneous Injuries

Satyanarayana Achanta iD, Narendranath Reddy Chintagari, Shrilatha Balakrishna, Boyi Liu, Sven-Eric Jordt

The Journal of Pharmacology and Experimental Therapeutics · 2024-02 · 388 (2) · 613-623

DOI: 10.1124/jpet.123.001666 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Pharmacology and Experimental Therapeutics, 2024-02. Verfasst von Satyanarayana Achanta und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Translational Pain Medicine, Department of Anesthesiology (S.A., B.L., S.-E.J.) and Department of Pharmacology and Cancer Biology (S.-E.J.…. Hauptthemen laut MEDLINE: o-Chlorobenzylidenemalonitrile, Transient Receptor Potential Channels, Chlorobenzenes. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIEHS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Deployment of the tear gas agent 2-chlorobenzalmalononitrile (CS) for riot control has significantly increased in recent years. The effects of CS have been believed to be transient and benign. However, CS induces severe pain, blepharospasm, lachrymation, airway obstruction, and skin blisters. Frequent injuries and hospitalizations have been reported after exposure. We have identified the sensory neuronal ion channel, transient receptor potential ankyrin 1 (TRPA1), as a key CS target resulting in acute irritation and pain and also as a mediator of neurogenic inflammation. Here, we examined the effects of pharmacologic TRPA1 inhibition on CS-induced cutaneous injury. We modeled CS-induced cutaneous injury by applying 10 μl CS agent [200 mM in dimethyl sulfoxide (DMSO)] to each side of the right ears of 8- to 9-week-old C57BL/6 male mice, whereas left ears were applied with solvent only (DMSO). The TRPA1 inhibitor HC-030031 or A-967079 was administered after CS exposure. CS exposure induced strong tissue swelling, plasma extravasation, and a dramatic increase in inflammatory cytokine levels in the mouse ear skin. We also showed that the effects of CS were not transient but caused persistent skin injuries. These injury parameters were reduced with TRPA1 inhibitor treatment. Further, we tested the pharmacologic activity of advanced TRPA1 antagonists in vitro. Our findings showed that TRPA1 is a crucial mediator of CS-induced nociception and tissue injury and that TRPA1 inhibitors are effective countermeasures that reduce key injury parameters when administered after exposure. Additional therapeutic efficacy studies with advanced TRPA1 antagonists and decontamination strategies are warranted. SIGNIFICANCE STATEMENT: 2-Chlorobenzalmalononitrile (CS) tear gas agent has been deployed as a crowd dispersion chemical agent in recent times. Exposure to CS tear gas agents has been believed to cause transient acute toxic effects that are minimal at most. Here we found that CS tear gas exposure causes both acute and persistent skin injuries and that treatment with transient receptor potential ion channel ankyrin 1 (TRPA1) antagonists ameliorated skin injuries.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

o-ChlorobenzylidenemalonitrileTransient Receptor Potential ChannelsChlorobenzenesMaleMiceAnimalsTear GasesAnkyrinsTRPA1 Cation ChannelDimethyl SulfoxideMice, Inbred C57BLPain

Substanzen

Tear GasesAnkyrins2-chlorobenzalmalononitrileTRPA1 Cation ChannelDimethyl Sulfoxideo-ChlorobenzylidenemalonitrileTransient Receptor Potential ChannelsChlorobenzenes

Autor:innen und Institutionen

  • Center for Translational Pain Medicine, Department of Anesthesiology (S.A., B.L., S.-E.J.) and Department of Pharmacology and Cancer Biology (S.-E.J.), Duke University School of Medicine, Durham, North Carolina; Departm…

ORCID-Profile: Satyanarayana Achanta

Förderung

  • NIEHS NIH HHS

Zitieren

APA

Achanta, S., Chintagari, N. R., Balakrishna, S., Liu, B., & Jordt, S. E. (2024). Pharmacologic Inhibition of Transient Receptor Potential Ion Channel Ankyrin 1 Counteracts 2-Chlorobenzalmalononitrile Tear Gas Agent–Induced Cutaneous Injuries. The Journal of Pharmacology and Experimental Therapeutics, 388(2), 613-623. https://doi.org/10.1124/jpet.123.001666

Vancouver

Achanta S, Chintagari NR, Balakrishna S, Liu B, Jordt SE. Pharmacologic Inhibition of Transient Receptor Potential Ion Channel Ankyrin 1 Counteracts 2-Chlorobenzalmalononitrile Tear Gas Agent–Induced Cutaneous Injuries. The Journal of Pharmacology and Experimental Therapeutics. 2024;388(2):613-623. doi:10.1124/jpet.123.001666

BibTeX
@article{Achanta2024,
  author = {Achanta, Satyanarayana and Chintagari, Narendranath Reddy and Balakrishna, Shrilatha and Liu, Boyi and Jordt, Sven-Eric},
  title = {Pharmacologic Inhibition of Transient Receptor Potential Ion Channel Ankyrin 1 Counteracts 2-Chlorobenzalmalononitrile Tear Gas Agent–Induced Cutaneous Injuries},
  journal = {The Journal of Pharmacology and Experimental Therapeutics},
  year = {2024},
  volume = {388},
  number = {2},
  pages = {613--623},
  doi = {10.1124/jpet.123.001666}
}
Kostenlos starten →